Dudrick S J, Latifi R, Adams P R
Hermann Hospital, Houston, Texas.
Surg Clin North Am. 1991 Jun;71(3):665-75. doi: 10.1016/s0039-6109(16)45440-x.
In a large subset of patients with atherosclerotic cardiovascular disease, all medical and surgical treatment alternatives have been exhausted or have proved to be ineffective. Intravenous infusion of specially formulated amino acid solutions, developed in the animal laboratory, has been efficacious in arresting and reversing atherosclerosis in humans for the first time. It is anticipated that the principles derived from these precise parenteral studies will eventually permit development of oral and enteral dietary formulations effective for the systemic control and management of atherosclerosis.
在很大一部分动脉粥样硬化性心血管疾病患者中,所有的药物和手术治疗方案都已用尽或被证明无效。在动物实验室研发的特制氨基酸溶液静脉输注首次在人类中有效阻止并逆转了动脉粥样硬化。预计从这些精确的肠外研究中得出的原理最终将促成有效的口服和肠内饮食配方的开发,用于系统性控制和管理动脉粥样硬化。